Hemodialysis Management in Pregnancy
For pregnant women with end-stage kidney disease, intensive hemodialysis should be provided with a target of 36+ hours per week (at least 6 sessions weekly) and maintaining predialysis BUN levels below 35 mg/dL to optimize maternal and fetal outcomes. 1, 2, 3
Dialysis Prescription for Pregnant Women
Frequency and Duration
- Provide intensive hemodialysis with at least 6 sessions per week, totaling 36-48 hours weekly 1
- A dose-response relationship exists between dialysis intensity and pregnancy outcomes, with live birth rates of:
- 48% with ≤20 hours/week
- 75% with 30 hours/week
- 85% with >36 hours/week 1
Target BUN Levels
- Maintain predialysis BUN <35 mg/dL (this is the optimal cutoff associated with better fetal outcomes) 2, 3
- Lower BUN levels correlate significantly with:
Dialysis Adequacy Measures
- For pregnant women, standard adequacy targets (spKt/V 1.4 per session) are insufficient 1
- Aim for higher clearance with a standard Kt/V of at least 2.3 volumes per week 1
- Monitor residual kidney function regularly, as it contributes to overall clearance 1
Technical Considerations
Dialysis Parameters
- Use biocompatible dialysis membranes 1
- Limit ultrafiltration to avoid hemodynamic instability that could compromise placental perfusion 4
- Consider microdose heparin to minimize bleeding risk while preventing clotting 4
Monitoring During Dialysis
- Closely monitor vital signs, particularly blood pressure, to avoid hypotension 1
- Regular assessment of fluid status is essential to prevent both dehydration and fluid overload 5, 6
- Proper BUN sampling techniques are crucial for accurate monitoring:
Expected Outcomes
- With intensive hemodialysis (>36 hours/week) and BUN <35 mg/dL:
Common Pitfalls and Considerations
- Inadequate dialysis intensity is a major pitfall - conventional thrice-weekly dialysis is insufficient for pregnant women 1
- Failure to monitor and maintain BUN <35 mg/dL correlates with poorer outcomes 2, 3
- Medication adjustments are necessary during pregnancy:
- Antihypertensives may need modification
- Anemia management requires close attention
- Mineral-bone disease medications often need adjustment 7
- Risk factors for adverse fetal outcomes include:
- Preeclampsia
- Lupus
- Primigravida status
- Higher average midweek BUN levels 2